FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

385275000: Cutaneous AND/OR transdermal dosage form (qualifier value)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1479527018 Cutaneous AND/OR transdermal dosage form en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2660179010 Cutaneous AND/OR transdermal dosage form (qualifier value) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    161731000077114 forme pharmaceutique pour usage transdermique et/ou cutané fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    forme pharmaceutique pour usage transdermique et/ou cutané Is a Type of drug preparation false Inferred relationship Some
    forme pharmaceutique pour usage transdermique et/ou cutané Is a forme pharmaceutique selon la voie d'administration false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Mafenide acetate 85mg/g cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Mafenide acetate 5% powder for injection solution Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Sulfacetamide 10% lotion Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Product containing precisely sulconazole nitrate 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Butenafine hydrochloride 1% cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Haloprogin 1% cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Haloprogin 10 mg/mL cutaneous solution Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Oxiconazole nitrate 1% cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Oxiconazole nitrate 1% lotion Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Clioquinol+hydrocortisone 3%/0.5% cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Naftifine hydrochloride 1% gel Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Iodoquinol+hydrocortisone 1%/1% cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Product containing precisely metronidazole 7.5 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Scopolamine 0.5mg/24 hr patch Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Product containing precisely glyceryl trinitrate 200 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Product containing precisely glyceryl trinitrate 300 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Nitroglycerin 0.6mg/hr Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Nitroglycerin 0.1mg/hr Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Nitroglycerin 0.2mg/hr Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Nitroglycerin 0.4mg/hr Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Alitretinoin 0.1% gel Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Monobenzone 20% cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Product containing precisely methoxsalen 10 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Hexachlorophene 30 mg/mL cutaneous emulsion Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Product containing precisely Podophyllum resin 250 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Methoxsalen 20mcg/mL injection solution 10mL vial Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Methoxsalen 10mg/mL lotion Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Cantharidin 0.7% liquid Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Nitroglycerin 0.2mg/hr disc Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Nitroglycerin 0.3mg/hr disc Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Nitroglycerin 0.4mg/hr disc Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Scopolamine 1.5mg/unt patch Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Hexachlorophene 3% soap Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Product containing precisely becaplermin 100 microgram/1 gram conventional release cutaneous gel (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Halobetasol propionate 0.05% cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Halobetasol propionate 0.05% ointment Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Product containing precisely chloroxine 20 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Podofilox 0.5% gel Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Glyceryl trinitrate 800 microgram/hour prolonged-release transdermal patch Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Product containing precisely glyceryl trinitrate 400 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Product containing precisely glyceryl trinitrate 600 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Product containing precisely amphotericin B 30 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Product containing precisely sulfacetamide sodium 100 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Product containing precisely lidocaine hydrochloride 30 milligram/1 milliliter conventional release cutaneous cream (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Mafenide acetate 112mg cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Mafenide acetate 5% powder Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Betamethasone valerate 0.12% aerosol Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Amphotericin B 30 mg/mL cutaneous cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Naftifine hydrochloride 1.0% cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Amcinonide 1 mg/mL cutaneous cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Diflorasone diacetate 0.5mg ointment Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Product containing precisely diflorasone diacetate 500 microgram/1 milliliter conventional release cutaneous cream (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Gentamicin sulfate 1% cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Gentamicin sulfate 0.1% cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Calcipotriene hydrate 0.005% cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Product containing precisely clindamycin phosphate 10 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Flurandrenolide 4mcg tape Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Fludroxycortide 500 microgram/mL cutaneous lotion Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Hydroquinone 30mg solution Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Product containing precisely hydroquinone 30 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Hydroquinone 4% gel Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Anthralin 0.25% topical cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Hydrocortisone valerate 2 mg/g cutaneous ointment Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Product containing precisely hydrocortisone valerate 2 milligram/1 milliliter conventional release cutaneous cream (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Betamethasone dipropionate 0.05% lotion Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Betamethasone dipropionate 0.05% gel Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Lidocaine hydrochloride 4% solution Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Betamethasone dipropionate 0.5mg/g cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Betamethasone dipropionate 0.5mg/g ointment Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Clonidine 2.5mg/unt Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Betamethasone dipropionate 0.5mg cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Betamethasone dipropionate 0.5% ointment Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Benzoyl peroxide 10% Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram conventional release cutaneous lotion (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 gram conventional release cutaneous cream (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Triamcinolone acetonide 1 mg/g cutaneous ointment Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Triamcinolone acetonide 250 microgram/mL cutaneous cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Product containing precisely triamcinolone acetonide 5 milligram/1 milliliter conventional release cutaneous cream (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Hydrocortisone acetate 30mg Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Benzoyl peroxide 4% lotion Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Benzoyl peroxide 3% gel Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Benzoyl peroxide 4% gel Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Benzoyl peroxide 8% gel Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Benzoyl peroxide 8% lotion Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Benzoyl peroxide 8% cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Benzoyl peroxide 10% cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Benzoyl peroxide 5% topical wash Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Benzoyl peroxide 6% gel Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Adapalene 0.1% solution Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Tretinoin 1 mg/g cutaneous gel Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Product containing precisely tretinoin 200 microgram/1 milliliter conventional release cutaneous cream (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Tretinoin 1 mg/mL cutaneous cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Calcipotriene 0.005% solution Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Calcipotriene 0.005% ointment Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Dexamethasone 10mg/25g Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Nystatin 100 unit/mg cutaneous powder Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Fluocinonide 500 microgram/g cutaneous gel Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Product containing precisely fluocinonide 500 microgram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Desonide 500 microgram/mL cutaneous cream Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Product containing precisely desonide 500 microgram/1 milliliter conventional release cutaneous lotion (clinical drug) Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some
    Desonide 500 microgram/g cutaneous ointment Has manufactured dose form False forme pharmaceutique pour usage transdermique et/ou cutané Inferred relationship Some

    Start Previous Page 8 of 13 Next End


    Reference Sets

    Concept inactivation indicator reference set

    POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)

    Back to Start